title: TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.
abstract: Disruption of intestinal epithelial homeostasis, including enhanced apoptosis, is a hallmark of inflammatory bowel disease (IBD). We have recently shown that tumor necrosis factor (TNF) increases the kinase activity of ErbB4, a member of the epidermal growth factor receptor family that is elevated in mucosa of IBD patients and that promotes colon epithelial cell survival. In this study, we tested the hypothesis that TNF transactivates ErbB4 through TNF-α converting enzyme (TACE)-mediated ligand release and that this transactivation is necessary to protect colonic epithelial cells from cytokine-induced apoptosis. Using neutralizing antibodies, we show that heparin-binding EGF-like growth factor (HB-EGF) is required for ErbB4 phosphorylation in response to TNF. Pharmacological or genetic inhibition of the metalloprotease TACE, which mediates HB-EGF release from cells, blocked TNF-induced ErbB4 activation. MEK, but not Src or p38, was also required for transactivation. TACE activity and ligand binding were required for ErbB4-mediated antiapoptotic signaling; whereas mouse colon epithelial cells expressing ErbB4 were resistant to TNF-induced apoptosis, TACE inhibition or blockade of ErbB4 ligand binding reversed the survival advantage. We conclude that TNF transactivates ErbB4 through TACE-dependent HB-EGF release, thus protecting colon epithelial cells from cytokine-induced apoptosis. These findings have important implications for understanding how ErbB4 protects the colon from apoptosis-induced tissue injury in inflammatory conditions such as IBD.
authors: Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
authors: Valda C
authors: VC
authors: Hilliard
authors: Mark R
authors: MR
authors: Frey
authors: Peter J
authors: PJ
authors: Dempsey
authors: Richard M
authors: RM
authors: Peek
authors: D Brent
authors: DB
authors: Polk
references: Int J Cancer. 2010 Jan 15;126(2):545-62
references: 19609946
references: Ann Rheum Dis. 2001 Nov;60 Suppl 3:iii25-32
references: 11890648
references: World J Gastroenterol. 2007 Nov 28;13(44):5877-87
references: 17990353
references: Mol Cell Neurosci. 2000 Nov;16(5):631-48
references: 11083924
references: J Clin Invest. 2009 Sep;119(9):2702-13
references: 19690388
references: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11772-7
references: 18701712
references: Inflamm Bowel Dis. 2006 May;12(5):413-24
references: 16670531
references: Proc Natl Acad Sci U S A. 2006 May 2;103(18):6901-6
references: 16641105
references: Chem Biol. 2008 Aug 25;15(8):808-17
references: 18721752
references: J Exp Med. 2010 Aug 2;207(8):1617-24
references: 20603312
references: J Pathol. 1996 Oct;180(2):152-9
references: 8976873
references: Am J Surg. 2008 May;195(5):604-10
references: 18424279
references: Gastroenterology. 2009 Apr;136(4):1297-1307, e1-3
references: 19250983
references: J Biol Chem. 2004 Nov 12;279(46):47929-38
references: 15337756
references: Growth Factors. 2006 Jun;24(2):121-36
references: 16801132
references: Nature. 1999 Dec 23-30;402(6764):884-8
references: 10622253
references: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):587-91
references: 7678459
references: Biochem J. 2010 May 13;428(2):293-304
references: 20331435
references: J Cell Sci. 2005 Jun 1;118(Pt 11):2371-80
references: 15923650
references: Anticancer Res. 2009 Jan;29(1):229-34
references: 19331154
references: Gastroenterology. 2009 Jan;136(1):217-26
references: 18973758
references: Nat Rev Drug Discov. 2005 Dec;4(12):988-1004
references: 16341064
references: Gut. 2002 Jul;51(1):37-43
references: 12077089
references: J Biol Chem. 2004 Jun 4;279(23):24179-88
references: 15066986
references: J Gastroenterol Hepatol. 2002 Jul;17(7):758-64
references: 12121505
references: Mol Biol Cell. 2002 Jun;13(6):2031-44
references: 12058067
references: J Biol Chem. 2003 Sep 26;278(39):37459-64
references: 12878595
references: Int J Cancer. 2006 Mar 15;118(6):1426-9
references: 16187281
references: Lab Invest. 2010 Oct;90(10):1415-24
references: 20585313
references: Cytokine. 2001 Dec 21;16(6):220-6
references: 11884025
references: J Biol Chem. 2003 Oct 31;278(44):42829-39
references: 12941954
references: Gastroenterology. 2010 Jun;138(6):2101-2114.e5
references: 20420949
references: Int J Mol Med. 2009 Jan;23(1):41-8
references: 19082505
references: Hypertension. 2009 Sep;54(3):575-82
references: 19581512
references: Growth Factors. 2002 Mar;20(1):1-15
references: 11999214
references: Eur J Cancer. 2002 May;38(8):1065-71
references: 12008194
references: Trends Biochem Sci. 2005 Jul;30(7):413-22
references: 15949939
references: Mol Cell. 2010 Feb 26;37(4):551-66
references: 20188673